December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024December 15 - 18, 2024
Marriott Marquis San Diego,
Live In-Person Event: December 15 - 18, 2024
Marriott Marquis San Diego,
Live In-Person Event: December 15 - 18, 2024
ANTIBODY ENGINEERING & THERAPEUTICS: THE 2023 ADVISORY BOARD
Antibody Engineering & Therapeutics US 2023 as been created in conjunction with leading experts and scientists from across the Antibody community.
Take a look at the advisory board to see who played a part in this year's schedule.
The 2023 Advisory Board
- Gregory Adams, Ph.D., Chief Scientific Officer, Elucida Oncology
- Andrew Bradbury, M.D., Ph.D., Chief Scientific Officer, Specifica
- Jean-Philippe Bürckert, Ph.D., Director of Informatics, Charles River Laboratories
- Dennis R. Burton, Ph.D., Professor, Department of Immunology and Microbiology, The Scripps Research Institute
- Kerry A. Chester, Ph.D., Professor of Molecular Medicine, UCL Cancer Institute, University College London, United Kingdom
- Jennifer Cochran, Ph.D., Professor and Department Chair of Bioengineering, StanfordUniversity
- Katherine Harris, Ph.D., Vice President, Discovery, Amgen
- Mitchell Ho, Ph.D., Senior Investigator, Laboratory of Molecular Biology, NIH NCI
- James Larrick, M.D., Ph.D., Managing Director and Chief Medical Officer, Panorama Research Institute and Velocity Pharmaceutical Development
- Paul W.H.I. Parren, Ph.D., Professor, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center and EVP and Head of R&D, Lava Therapeutics, The Netherlands
- Andreas Plückthun, Ph.D., Professor and Director, Department of Biochemistry, University of Zürich, Switzerland
- Nina Luning Prak, M.D., Ph.D., Professor of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania
- Sai Reddy, Ph.D., Associate Professor, Department of Biosystems Science and Engineering, ETH Zurich/Swiss Federal Institute of Technology, Switzerland
- Janice M. Reichert, Ph.D., Executive Director, The Antibody Society; Editor-in-Chief, mAbs; Managing Director, Reichert Biotechnology Consulting LLC
- Janine Schuurman, Ph.D., Antibody Industry Expert and Board Member, The Antibody Society, The Netherlands
- Jonathan Sockolosky, Ph.D., Director, Company Value Creation, Curie.Bio
- Sally Ward, Ph.D., Professor and Director, University of Southampton, United Kingdom
- K. Dane Wittrup, Ph.D., C.P. Dubbs Professor of Chemical Engineering and Biological Engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology